Inhibrx Biosciences, Inc. - INBX

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$1.108B
QoQ value delta ($000)
+$753.3M (+212.54%)
Implied price effect (QoQ)
+134.58%
Shares
Total shares
14,022,855
QoQ shares delta
+3,497,962 (+33.24%)
Total shares held by funds (by quarter)

Market chart (INBX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 10 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
PERCEPTIVE ADVISORS LLC 114,763 1,452,707 2.05%
VIKING GLOBAL INVESTORS LP 113,578 1,437,705 0.3%
MORGAN STANLEY 92,250 1,167,728 0.01%
Sanofi 91,476 1,157,926 29.47%
HighTower Advisors, LLC 68,770 870,507 0.08%
BlackRock, Inc. 61,413 777,383 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 49,960 632,416 0.01%
VANGUARD GROUP INC 49,223 623,084 0.0%
Caligan Partners LP 37,411 473,565 3.08%
Sofinnova Investments, Inc. 35,917 454,657 1.55%
Capital Research Global Investors 33,304 421,575 0.01%
STATE STREET CORP 29,621 374,961 0.0%
MILLENNIUM MANAGEMENT LLC 21,797 275,917 0.01%
PFM Health Sciences, LP 20,975 265,517 2.09%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 20,856 264,000 0.03%
GEODE CAPITAL MANAGEMENT, LLC 17,858 226,009 0.0%
Schonfeld Strategic Advisors LLC 16,963 214,725 0.08%
CITADEL ADVISORS LLC 16,439 208,100 0.0%
DLD Asset Management, LP 16,174 204,600 1.2%
GOLDMAN SACHS GROUP INC 13,202 167,117 0.0%
D. E. Shaw & Co., Inc. 11,439 144,801 0.01%
Woodline Partners LP 11,018 139,479 0.04%
BOOTHBAY FUND MANAGEMENT, LLC 10,634 134,609 0.16%
NORGES BANK 10,530 133,300 0.0%
JANE STREET GROUP, LLC 9,710 122,919 0.0%